National Institutes of Health
November 18, 2021
Researchers at U-M, Michigan State University and Oakland University are teaming up to develop wearable technology able to identify particulate matter pollution such as soot and toxic metals.
October 6, 2021
A $3.6 million project funded by the National Institutes of Health will allow a team of experts from U-M to explore many factors to better determine what makes someone more likely to develop ALS, also known as Lou Gehrig’s disease.
October 4, 2021
In an effort to bring robotic assistance to workers, the elderly and more, a U-M team is developing a new type of powered exoskeleton for lower limbs — funded by $1.7 million from the National Institutes of Health.
September 7, 2021
Short news items from around the University of Michigan.
September 1, 2021
The National Institutes of Health will award an estimated $15.3 million over the next five years to expand a collaboration between U-M, Michigan State University and Wayne State University that aims to accelerate progress in Alzheimer’s disease research.
June 10, 2021
Gregory Eschenauer, clinical associate professor at the College of Pharmacy, has been appointed to the NIH COVID-19 Treatment Guideline Panel, convened by Anthony Fauci.
May 10, 2021
Michigan CEAL: Communities Conquering COVID has been awarded an additional $1.4 million dollars to support an additional year of community-based COVID-19 interventions.
January 27, 2021
A U-M engineering professor and 18 colleagues are calling on the National Institutes of Health and other funding agencies to address why white researchers are nearly twice as likely to be awarded a grant than Black scientists.
November 10, 2020
U-M reported $1.62 billion in research volume during fiscal year 2020, which led to important advancements in a range of areas. The university maintained the same total research volume as FY ’19.
November 5, 2020
A four-year $3.3 million grant will allow researchers from the School of Public Health to take part in a study of the ethical, legal and social implications of workplace genomic testing in the United States.